Disclosure Of Interests In Other Entities [Text Block]

ERYTECH Pharma S.A. - Filing #880081

Concept 2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
As at
2019-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
2019-01-01 to
2019-12-31
Disclosure of interests in other entities [text block]
Disclosure of interests in subsidiaries [text block]
Disclosure of subsidiaries [text block]
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Current assets
40 048 EUR
49 632 EUR
81 583 EUR
Non-current assets
26 720 EUR
30 770 EUR
36 962 EUR
Current liabilities
20 005 EUR
29 347 EUR
19 880 EUR
Non-current liabilities
23 918 EUR
24 516 EUR
13 105 EUR
Revenue
EUR
EUR
EUR
Profit (loss)
53 797 EUR
53 797 EUR
73 300 EUR
73 300 EUR
62 659 EUR
62 659 EUR
Comprehensive income
68,000 EUR
EUR
528,000 EUR
53 797 EUR
EUR
54 257 EUR
72 919 EUR
19,000 EUR
EUR
400,000 EUR
EUR
73 300 EUR
38,000 EUR
1 237 EUR
61 460 EUR
EUR
62 659 EUR
EUR
Disclosure of interests in associates [text block]
Disclosure of associates [text block]
Disclosure of associates [abstract]
Disclosure of associates [line items]
Other comprehensive income
68,000 EUR
528,000 EUR
460,000 EUR
381,000 EUR
19,000 EUR
400,000 EUR
38,000 EUR
1 237 EUR
1 199 EUR
Disclosure of interests in joint arrangements [text block]
Disclosure of joint ventures [text block]
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents
33 699 EUR
44 446 EUR
73 173 EUR
Tax expense (income)
2,000 EUR
3,000 EUR
1,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.